Mucosal infections involve the invasion of mucosal surfaces lining various organs, such as the respiratory, gastrointestinal, and urogenital tracts, by pathogenic microorganisms. These infections can be caused by bacteria, viruses, fungi, or parasites and often result in a range of diseases depending on the affected mucosal site. Mucosal surfaces serve as the body's first line of defense against pathogens, featuring specialized immune components like mucins, antimicrobial peptides, and immunoglobulin A (IgA). However, pathogens have evolved strategies to circumvent these defenses, leading to infections. Common mucosal infections include respiratory infections like influenza and pneumonia, gastrointestinal infections such as gastroenteritis, and urogenital infections like urinary tract infections. Transmission typically occurs through direct contact, ingestion, or inhalation of contaminated materials. Understanding mucosal immunity is crucial for developing effective vaccines and therapies against mucosal infections. Research in this field focuses on elucidating the interactions between pathogens and the mucosal immune system, exploring vaccination strategies that induce mucosal immunity, and developing targeted interventions to prevent and treat mucosal infections.
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan